TRVI logo

Trevi Therapeutics, Inc. (TRVI) Cash From Investing

Annual CFI:

-$21.53M-$80.96M(-136.23%)
December 31, 2024

Summary

  • As of today, TRVI annual cash from investing is -$21.53 million, with the most recent change of -$80.96 million (-136.23%) on December 31, 2024.
  • During the last 3 years, TRVI annual cash from investing has fallen by -$21.53 million (-100.00%).
  • TRVI annual cash from investing is now -136.23% below its all-time high of $59.43 million, reached on December 31, 2023.

Performance

1-Year Change

-136.23%

3-Year Change

-100%

5-Year Change

-239100%

15-Year Change

-165500%

TRVI Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

29.63%
TRVI annual cash from investing is higher than 29.63% of companies in Healthcare sector

Range

All-Time High

$59.43M
TRVI annual cash from investing is currently -136.23% below its historical high of $59.43 million

3-Year Low

-$107.37M
TRVI annual cash from investing is currently +79.95% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
TRVI previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
TRVI next annual earnings announcement has not yet been scheduled

OtherTRVIcash flow metrics

Annual CFF

$61.48M
TRVI annual cash from financing is $61.48 million

Annual CFO

-$38.26M
TRVI annual cash from operations is -$38.26 million

Annual FCF

-$38.29M
TRVI annual free cash flow is -$38.29 million

Annual CAPEX

$35.00K
TRVI annual capital expenditures is $35.00 thousand

Quarterly CFI:

-$2.61M+$7.34M(+73.77%)
June 30, 2025

Summary

  • As of today, TRVI quarterly cash from investing is -$2.61 million, with the most recent change of +$7.34 million (+73.77%) on June 30, 2025.
  • Over the past year, TRVI quarterly cash from investing has dropped by -$5.38 million (-194.29%).
  • TRVI quarterly cash from investing is now -113.29% below its all-time high of $19.64 million, reached on June 30, 2023.

Performance

3-Month Change

+73.77%

1-Year Change

-194.29%

3-Year Change

+95.19%

5-Year Change

-21650%

TRVI Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

27.14%
TRVI quarterly cash from investing is higher than 27.14% of companies in Healthcare sector

Range

All-Time High

$19.64M
TRVI quarterly cash from investing is currently -113.29% below its historical high of $19.64 million

3-Year Low

-$48.31M
TRVI quarterly cash from investing is currently +94.60% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
TRVI previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Nov 13, 2025
TRVI next earnings announcement is scheduled for Nov 13, 2025

OtherTRVIcash flow metrics

Quarterly CFF

$110.39M
TRVI quarterly cash from financing is $110.39 million

Quarterly CFO

-$10.10M
TRVI quarterly cash from operations is -$10.10 million

Quarterly FCF

-$10.10M
TRVI quarterly free cash flow is -$10.10 million

Quarterly CAPEX

$0.00
TRVI quarterly capital expenditures is $0.00

TTM CFI:

-$28.77M-$5.38M(-22.99%)
June 30, 2025

Summary

  • As of today, TRVI TTM cash from investing is -$28.77 million, with the most recent change of -$5.38 million (-22.99%) on June 30, 2025.
  • Over the past year, TRVI TTM cash from investing has dropped by -$54.27 million (-212.79%).
  • TRVI TTM cash from investing is now -148.40% below its all-time high of $59.43 million, reached on December 31, 2023.

Performance

3-Month Change

-22.99%

1-Year Change

-212.79%

3-Year Change

+46.94%

5-Year Change

-106440.74%

TRVI TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

23.66%
TRVI TTM cash from investing is higher than 23.66% of companies in Healthcare sector

Range

All-Time High

$59.43M
TRVI TTM cash from investing is currently -148.40% below its historical high of $59.43 million

3-Year Low

-$107.37M
TRVI TTM cash from investing is currently +73.21% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
TRVI previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Nov 13, 2025
TRVI next earnings announcement is scheduled for Nov 13, 2025

OtherTRVIcash flow metrics

TTM CFF

$175.54M
TRVI TTM cash from financing is $175.54 million

TTM CFO

-$42.68M
TRVI TTM cash from operations is -$42.68 million

TTM FCF

-$42.69M
TRVI TTM free cash flow is -$42.69 million

TTM CAPEX

$7000.00
TRVI TTM capital expenditures is $7000.00

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

TRVI Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-136.2%-194.3%-212.8%
3Y3 Years-100.0%+95.2%+46.9%
5Y5 Years-10000.0%-10000.0%-10000.0%

TRVI Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-136.2%+80.0%-113.3%+94.6%-148.4%+73.2%
5Y5-Year-136.2%+80.0%-113.3%+95.2%-148.4%+73.2%
All-TimeAll-Time-136.2%+80.0%-113.3%+95.2%-148.4%+73.2%

TRVI Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$2.61M(+73.8%)
-$28.77M(-23.0%)
Mar 2025
-
-$9.95M(+58.3%)
-$23.39M(-8.6%)
Dec 2024
-$21.53M(-136.2%)
-$23.87M(-411.4%)
-$21.53M(-241.7%)
Sep 2024
-
$7.67M(+177.0%)
$15.19M(-40.4%)
Jun 2024
-
$2.77M(+134.2%)
$25.50M(-39.8%)
Mar 2024
-
-$8.09M(-163.0%)
$42.38M(-28.7%)
Dec 2023
$59.43M(+155.3%)
$12.85M(-28.6%)
$59.43M(+3549.1%)
Sep 2023
-
$17.98M(-8.4%)
-$1.72M(+93.0%)
Jun 2023
-
$19.64M(+119.1%)
-$24.55M(+75.0%)
Mar 2023
-
$8.96M(+118.6%)
-$98.41M(+8.3%)
Dec 2022
-$107.37M(>-9900.0%)
-$48.31M(-896.0%)
-$107.37M(-81.8%)
Sep 2022
-
-$4.85M(+91.1%)
-$59.07M(-8.9%)
Jun 2022
-
-$54.22M(>-9900.0%)
-$54.22M(>-9900.0%)
Mar 2022
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2021
$0.00
$0.00(0.0%)
$0.00(+100.0%)
DateAnnualQuarterlyTTM
Sep 2021
-
$0.00(0.0%)
-$5000.00(+75.0%)
Jun 2021
-
$0.00(0.0%)
-$20.00K(+37.5%)
Mar 2021
-
$0.00(+100.0%)
-$32.00K(0.0%)
Dec 2020
-$32.00K(-255.6%)
-$5000.00(+66.7%)
-$32.00K(-18.5%)
Sep 2020
-
-$15.00K(-25.0%)
-$27.00K(-125.0%)
Jun 2020
-
-$12.00K(>-9900.0%)
-$12.00K(>-9900.0%)
Mar 2020
-
$0.00(0.0%)
$0.00(+100.0%)
Dec 2019
-$9000.00(+94.3%)
$0.00(0.0%)
-$9000.00(+91.1%)
Sep 2019
-
$0.00(0.0%)
-$101.00K(0.0%)
Jun 2019
-
$0.00(+100.0%)
-$101.00K(+9.0%)
Mar 2019
-
-$9000.00(+90.2%)
-$111.00K(-8.8%)
Dec 2018
-$158.00K(-1115.4%)
-$92.00K(-820.0%)
-$102.00K(-920.0%)
Jun 2018
-
-$10.00K
-$10.00K
Dec 2017
-$13.00K(>-9900.0%)
-
-
Dec 2016
$0.00
-
-

FAQ

  • What is Trevi Therapeutics, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Trevi Therapeutics, Inc.?
  • What is Trevi Therapeutics, Inc. annual cash from investing year-on-year change?
  • What is Trevi Therapeutics, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Trevi Therapeutics, Inc.?
  • What is Trevi Therapeutics, Inc. quarterly cash from investing year-on-year change?
  • What is Trevi Therapeutics, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Trevi Therapeutics, Inc.?
  • What is Trevi Therapeutics, Inc. TTM cash from investing year-on-year change?

What is Trevi Therapeutics, Inc. annual cash from investing?

The current annual cash from investing of TRVI is -$21.53M

What is the all-time high annual cash from investing for Trevi Therapeutics, Inc.?

Trevi Therapeutics, Inc. all-time high annual cash from investing is $59.43M

What is Trevi Therapeutics, Inc. annual cash from investing year-on-year change?

Over the past year, TRVI annual cash from investing has changed by -$80.96M (-136.23%)

What is Trevi Therapeutics, Inc. quarterly cash from investing?

The current quarterly cash from investing of TRVI is -$2.61M

What is the all-time high quarterly cash from investing for Trevi Therapeutics, Inc.?

Trevi Therapeutics, Inc. all-time high quarterly cash from investing is $19.64M

What is Trevi Therapeutics, Inc. quarterly cash from investing year-on-year change?

Over the past year, TRVI quarterly cash from investing has changed by -$5.38M (-194.29%)

What is Trevi Therapeutics, Inc. TTM cash from investing?

The current TTM cash from investing of TRVI is -$28.77M

What is the all-time high TTM cash from investing for Trevi Therapeutics, Inc.?

Trevi Therapeutics, Inc. all-time high TTM cash from investing is $59.43M

What is Trevi Therapeutics, Inc. TTM cash from investing year-on-year change?

Over the past year, TRVI TTM cash from investing has changed by -$54.27M (-212.79%)
On this page